SUBSCRIBERS

TalkMed's Q4 net profit dips 19.3% y-o-y on fewer patient visits

Published Wed, Feb 21, 2018 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

CATALIST-listed healthcare provider TalkMed Group - whose chief executive officer (CEO) and main revenue contributor was suspended by the Singapore Medical Council (SMC) last year - saw its fourth-quarter net profit fall 19.3 per cent to S$8.24 million from S$10.22 million a year ago.

This translated to an earnings per share of 0.63 Singapore cent for the quarter, from 0.78 Singapore cent in the year-ago period.

Copyright SPH Media. All rights reserved.